Second medical opinion in oncological setting.
AIOM
Decalogue
Ethics
Meeting
Second medical opinions
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
27
06
2020
revised:
23
01
2021
accepted:
27
02
2021
pubmed:
7
3
2021
medline:
21
4
2021
entrez:
6
3
2021
Statut:
ppublish
Résumé
Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical Oncology) and AIOM Foundation faced this topic during the 7th Annual Meeting on Ethics in Oncology (Ragusa, 4-5 t h May 2018). In this position paper we report reasons, limits, advantages and outcomes of second medical opinion and the respective Decalogue in the oncological setting.
Identifiants
pubmed: 33675905
pii: S1040-8428(21)00070-6
doi: 10.1016/j.critrevonc.2021.103282
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103282Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.